The Global Bioreactor Market by Material, Usage, Scale, Control Type and Geography - Forecast to 2023: Growing at Approx 6.8% CAGR - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Mar 12, 2019--The “Bioreactor Market Size, Share - Segmented by Material, Usage, Scale, Control Type (Manual and Automated), and Geography - Growth, Trend, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.
The global bioreactor market is projected to record a CAGR of approximately 6.8% during the forecast period (2018-2023).
The global bioreactor market is experiencing considerable growth, due to factors, like rising biopharmaceutical investments, which may drive the global bioreactor market size, and growing demand for therapeutically effective vaccines and product innovation.
Growth of Bioreactor in Pharmaceutical Boost the Growth of the Bioreactor Market
Biopharmaceuticals are utilized in a range of applications, from being in the production of biopharmaceutical to applications in tissue engineering, such as cell expansion and generation of 3D tissue constructs. Bioreactors are providing controllable environment, in terms of pH, temperature, nutrient supply, and shear stress for any cells or cellular constructs incorporated into them.
Bioreactors have been utilized in many different areas of industry and research, and for the progression of in vitro models of 2D cultures and suspensions to 3D constructs mimicking the natural physiological state in situ, and they have proven to be crucial. Monoclonal medicines that are used in autoimmune disorders, cancer, asthma, and organ rejection are produced in large (20,000L) bioreactors.
Thus, growth of bioreactors in the pharmaceutical sector is the major factor augmenting the growth of the market. Additionally, technological advancements in bioreactor and adoption of single-use bioreactors (SUBs) and hybrid bioreactors are some of the other factors augmenting the growth of the bioreactor market.
Concerns Regarding the Use of Single-use Bioreactors (SUBs) Hindering the Bioreactor Market
There are several concerns regarding the use of SUBs, which include them being non-customizable and lack of good practices to prevent leakage of Single Use Systems (SUS). Also, stirring is one of the key elements in the bioreactors system on which mass transfer and energy transfer depend on.
In wave bag type single-use bioreactors, the mixing principle is unconventional and limited to a rocking movement, which limits the use of such culture bags to low volume and simple applications, such as the seedtrain expansion of cells (inoculum production). In many cases, SUBs are also produced from plastic derivatives. In addition to validation concerns related to potential leachable and extractable materials, the largescale disposal of such plastic reactors on a regular basis is also an environmental concern.
Thus, concerns regarding the use of SUBs are acting as major restraints for the growth of the market. Additionally, limited storage capacity of bioreactor is also hindering the growth of the market.
North America has the Largest Share in the Global Bioreactor Market
The largest share of North America is attributed to the growing pharmaceutical industry in the region. According to International Trade Administration in 2016, the US pharmaceutical market is expected to value USD 320 billion by 2020. Thus, with the growth of the pharmaceutical companies in the United States, the market is also flourishing as these bioreactor processes are used extensively to produce specialty biomolecules for use in pharmaceutical industries. Also, other factors are increasing the demand for single-use technologies, which has encouraged companies to adopt the bioreactors.
Key Developments in the Bioreactor Market
- Apr 2018: Sartorius Stedim Biotech collaborated with Penn State University.
- Mar 2018: Danaher Corporation acquired Integrated DNA Technologies, which is a provider of high-value consumables for genomics applications in molecular biology.
- Pall Corporation (Danaher Corporation)
- Eppendorf AG
- Merck Millipore Corporation
- Sartorius AG
- Thermo Fisher Scientific Inc.
- Bioengineering AG
- Applikon Biotechnology Inc.
- Solaris Biotech
- Infors HT
- Pierre Guerin Technologies
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porters Five Forces
6. Market Dynamics
6.1 Bioreactor Market Drivers
6.1.1 Growth of Bioreactors in the Pharmaceutical Sector
6.1.2 Technological Advancements in Bioreactors
6.1.3 Adoption of Single-use Bioreactors (SUBs) and Hybrid Bioreactors
6.2 Bioreactor Market Restraints
6.2.1 Concerns Regarding the Use of Single-use Bioreactors (SUBs)
6.2.2 Limited Storage Capacity
6.3 Bioreactor Market Opportunities
6.4 Bioreactor Market Key Challenges
7. Market Segmentation
7.1 Bioreactor Market By Material
7.1.2 Stainless Steel
7.2 Bioreactor Market By Usage
7.2.1 Lab-scale Production
7.2.2 Pilot-scale Production
7.2.3 Full-scale Production
7.3 Bioreactor Market By Scale
7.3.4 Above 1500L
7.4 Bioreactor Market By Control Type
7.4.2 Automated (MFCs)
7.5 Bioreactor Market By Geography
7.5.1 North America
126.96.36.199 United States
188.8.131.52 United Kingdom
184.108.40.206 Rest of Europe
220.127.116.11 Australia & New Zealand
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
7.5.4 Middle East & Africa
126.96.36.199 South Africa
188.8.131.52 Rest of Middle East & Africa
7.5.5 South America
184.108.40.206 Rest of South America
8. Bioreactor Market Company Profiles and Competitive Landscape
8.1 Applikon Biotechnology Inc.
8.2 Bioengineering AG
8.3 Eppendorf AG
8.4 Infors HT
8.5 Merck Millipore Corporation
8.6 Pall Corporation (Danaher Corporation)
8.7 Pierre Guerin Technologies
8.8 Sartorius AG
8.9 Solaris Biotech
8.10 Thermo Fisher Scientific Inc.
9. Future of the Bioreactor Market
For more information about this report visit https://www.researchandmarkets.com/research/cjrxks/the_global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190312005581/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 03/12/2019 10:14 AM/DISC: 03/12/2019 10:14 AM